U.S. CDC Tested
Each Asanté ® HIV-1 Rapid Recency ® Assay lot is performance tested by both Sedia’s Quality Control Department and by the U.S. Centers for Disease Control prior to market release.
Certification of CDC testing can be provided upon request.
Contains Three Reaction Lines
Control line indicates the specimen was properly added and the test functioned properly.
Verification line ensures HIV-negative specimens are excluded.
LT/R line differentiates recent from long-term specimens.